Capillary Technologies shareholders approve FY26 results, reappoint CEO

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Shareholders approved FY26 standalone and consolidated financial statements with negligible opposition
  • Revenue grew 23% YoY to ₹7,436 million while adjusted EBITDA surged 43% to ₹1,069 million
  • Managing Director and CEO Aneesh Reddy Boddu was re-appointed as director retiring by rotation
  • Promoter group cast 99.28% of their votes in favor of all resolutions
powered bylight_fuzz_icon
49467117

*this image is generated using AI for illustrative purposes only.

Capillary Technologies India Limited shareholders unanimously approved the company's FY26 audited financial statements and the re-appointment of Managing Director and CEO Aneesh Reddy Boddu during its 14th Annual General Meeting on August 28, 2026.

The scrutinizer's report, issued by BMP & Co. LLP on August 31, 2026, confirms that all three ordinary resolutions passed with requisite majority. Voting was conducted via remote e-voting and during the meeting through video conferencing.

Financial Performance Recap

During the proceedings, Mr. Boddu highlighted the company's financial performance for FY25-26. The firm reported revenue of ₹7,436 million, marking a 23% year-on-year growth. Adjusted EBITDA rose by 43% to ₹1,069 million. These figures underscore the company's ability to expand profitability at a faster pace than top-line growth during the period.

Key Operational Highlights

The management emphasized several strategic milestones achieved during the fiscal year:

  • Listing on the BSE in November 2025, with the IPO oversubscribed 52.95 times.
  • Recognition as a Leader in the Forrester Wave for Loyalty Platforms in Q4 2025.
  • Diversification across geographies and sectors.
  • Launch of AI-led initiatives, including the aiRA platform.

What the Numbers Show

The divergence between revenue growth (23%) and adjusted EBITDA growth (43%) indicates significant operating leverage. This suggests that fixed costs were spread over a larger revenue base or that variable cost management improved, allowing margins to expand disproportionately to sales growth.

Governance and Voting Details

Ms. Neelam Dhawan, Chairperson of the Company, presided over the meeting. The scrutinizer, Biswajit Ghosh of BMP & Co. LLP, verified the voting process which commenced on August 24, 2026, and concluded on August 27, 2026, for remote e-voting. Votes were unblocked on August 28, 2026, in the presence of independent witnesses.

Out of 19,452 shareholders on the record date (August 21, 2026), 105 members exercised their votes across the resolutions. The promoter group held 37,593,710 shares, while public institutions held 18,989,757 shares and non-institutional public shareholders held 23,005,264 shares.

Resolution Outcomes

All three resolutions were approved. The voting results for each resolution are detailed below:

Resolution Description Votes For Votes Against Result
Adoption of Audited Standalone Financial Statements for FY26 55,342,500 5 Approved
Adoption of Audited Consolidated Financial Statements for FY26 55,342,500 5 Approved
Re-appointment of Mr. Aneesh Reddy Boddu as Director 55,342,418 87 Approved

Shareholders participated actively, raising questions regarding the company's growth roadmap, R&D spend, working capital dynamics, geographic expansion, and AI-based product initiatives. Voting was conducted electronically via NSDL.

Historical Stock Returns for Capillary Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+5.39%+10.43%-0.64%+0.23%-15.89%-15.89%

How will Capillary Technologies plan to sustain its 43% EBITDA growth rate as it scales beyond the current operating leverage inflection point?

What specific revenue targets or market share goals has management set for the newly launched aiRA platform in the upcoming fiscal year?

Given the recent BSE listing, how does the company intend to balance capital allocation between R&D for AI initiatives and potential shareholder returns?

like15
dislike

Capillary Technologies promoter CTIPL sells 4.14% stake via block deal

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Promoter CTIPL sold 3,292,428 shares of Capillary Technologies India Limited via block deal on August 10, 2026, reducing its stake to 44.78%. The transaction was disclosed under SEBI SAST and PIT regulations. CTIPL remains a promoter with no encumbered shares.

powered bylight_fuzz_icon
48010822

*this image is generated using AI for illustrative purposes only.

Capillary Technologies International Pte. Ltd. (CTIPL), a promoter of capillary technologies , disposed of 3,292,428 equity shares through a block deal on August 10, 2026. The transaction, representing 4.14% of the company’s total paid-up equity share capital, reduces CTIPL’s stake from 48.92% to 44.78%. Although the sale marks a notable reduction in promoter holding, CTIPL retains its status as a promoter and maintains a controlling interest in the Bengaluru-based customer engagement technology firm. The disposal was executed on the National Stock Exchange of India Limited.

The disclosure was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Capillary Technologies India Limited received the intimation from CTIPL on August 10, 2026, and subsequently informed the stock exchanges on August 11, 2026. Gireddy Bhargavi Reddy, Company Secretary and Compliance Officer, signed the disclosure on behalf of the company.

Shareholding Structure Post-Transaction

Following the block deal, CTIPL’s shareholding has been adjusted as detailed below. The total paid-up equity share capital of Capillary Technologies India Limited remains unchanged at 79,471,983 equity shares.

Particulars Number of Equity Shares % of Paid-up Equity Share Capital
Shareholding prior to transaction 38,881,247 48.92%
Equity Shares sold 3,292,428 4.14%
Shareholding subsequent to transaction 35,588,819 44.78%

CTIPL holds no encumbrances, pledges, or liens on its remaining shares. There are no warrants, convertible securities, or other instruments entitling the acquirer to receive additional shares carrying voting rights. The voting rights held by CTIPL are solely derived from its direct shareholding.

Promoter Status and Regulatory Compliance

Despite the reduction in stake, CTIPL continues to be classified as a promoter of Capillary Technologies India Limited. The disclosure confirms that there are no Persons Acting in Concert (PAC) with CTIPL involved in this transaction. The mode of acquisition/sale was explicitly stated as a sale through a block deal on the stock exchange.

The transaction does not alter the total diluted share capital, which stands at 79,471,983 equity shares, assuming full conversion of outstanding convertible securities. The ESOP pool is not considered in this calculation. Ramendra Kumar Pandey, Director of CTIPL, signed the disclosure document from Singapore on August 10, 2026.

Historical Stock Returns for Capillary Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+5.39%+10.43%-0.64%+0.23%-15.89%-15.89%

What strategic rationale might drive CTIPL to reduce its stake while retaining controlling interest, and does this signal upcoming capital restructuring?

How will the reduction in promoter holding from 48.92% to 44.78% impact investor sentiment and short-term stock price volatility on the NSE?

Are there indications that the proceeds from this block deal will be reinvested into Capillary Technologies' core customer engagement technology initiatives or used for debt repayment?

like15
dislike

More News on Capillary Technologies

1 Year Returns:-15.89%